Answers are grounded in this paper and cite their sources.
Carcinogenicity assessment using rodent bioassays is constrained by interspecies differences, cost, duration, and ethical concerns, highlighting the need for human-relevant New Approach Methodologies (NAMs). Extracellular vesicles (EVs) are potential sources of molecular biomarkers, but heterogeneous EV-associated proteomic data can complicate the identification of mechanistically informative patterns. We present EV-PROTEOMICS, a database-driven computational framework for refining curated EV-associated protein profiles across predefined toxicological reference categories. Protein profiles were represented as binary data and processed using a subtractive refinement strategy. Twelve reference substances representing genotoxic and non-genotoxic categories were evaluated. Refinement reduced the genotoxicity-associated protein set from 245 to 119 proteins. Jaccard dissimilarity and Principal Coordinates Analysis showed that the proportion of variation represented by the first two axes increased from 31.2% in the initial dataset to 66.3% after refinement. Further mechanistic exploration prioritized candidates, including NDRG2 and NFE2L2, in profiles associated with aromatic amine/nitrosamine reference substances. These findings provide an in silico proof of concept for refining EV-associated protein datasets and generating candidate signatures for mechanistic toxicology research. Independent datasets and experimental studies are required to assess reproducibility and determine discriminatory or predictive performance.
No takes yet. Share an insight, caveat, or question.
Nascimento et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: